Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes.
Document Type
Journal Article
Publication Date
9-17-2015
Journal
New england journal of medicine
Volume
373
Issue
22
Inclusive Pages
2117-2128
DOI
10.1056/NEJMoa1504720
Keywords
Benzhydryl Compounds--therapeutic use; Cardiovascular Diseases--prevention & control; Diabetes Mellitus, Type 2--drug therapy; Glucosides--therapeutic use; Hypoglycemic Agents--therapeutic use
APA Citation
Zinman, B., Wanner, C., Lachin, J.M., Fitchett, D., Bluhmki, E., Hantel, S., Inzucchi, S.E. (2015). Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes." New England Journal of Medicine, 373(22), 2117-2128. doi:10.1056/NEJMoa1504720
Peer Reviewed
1